Latest Financials News

Amplia Therapeutics reported mature ACCENT trial data showing improved survival and multiple complete responses with narmafotinib, alongside a GMP production milestone and CFO appointment.

FortifAI’s Nol8 FPGA appliance dramatically reduces AI infrastructure costs by replacing up to 60,000 CPUs, slashing annual operational expenses from millions to tens of thousands of dollars.

Nexsen Limited has cleared a major FDA regulatory hurdle for its StrepSure rapid Group B Streptococcus test, confirmed a clear 510(k) submission pathway, and secured over A$1.7 million in non-dilutive grants to expand clinical validation and market rollout in Asia-Pacific and neonatal diagnostics.

Xamble Group stabilised revenue at A$1.64 million in Q1 2026 while narrowing its group EBITDA loss slightly despite ramped-up technology spending. The company completed its acquisition of YouthsToday, tripling its influencer base and locking in three commercial contracts worth A$1.17 million.

OncoSil Medical reported a 60% year-on-year increase in dose sales in Q3 FY26, boosted by expanding treatment centres and advancing clinical trials, while cost-cutting and a new manufacturing facility aim to underpin growth.

Horizon Gold has confirmed new high-grade gold shoots at its Kingfisher prospect, underpinning resource growth potential, while progressing a major $30 million capital raise and leadership transition.

Entropy Neurodynamics has reported encouraging early clinical outcomes from its pioneering intravenous psilocin therapy for Binge Eating Disorder, alongside a patent grant that strengthens its intellectual property moat.

Red Metal Limited is progressing key rare earth and base metal projects across Australia, securing government grants and proposing a major Maronan Metals share distribution to shareholders.

Australis Oil & Gas has partnered with a major US-listed company to develop its Tuscaloosa Marine Shale assets, retaining a 10% interest in producing wells and holding a strong cash position after recent transactions.

Emyria reported $1.2 million revenue for Q1 2026 driven by insurer-funded clinics and expanded its Empax network across multiple states. It launched a Global Partnership Program targeting international drug sponsors, leveraging its clinical infrastructure amid growing global interest in psychedelic therapies.

CZR Resources has launched a new drilling campaign at its Croydon Gold Project, focusing on extending known mineralisation and testing for high-grade ore shoots and Hemi-style intrusions. The program leverages recent geological insights and a robust $67 million cash position.

Etherstack has smashed its first half revenue record for FY26 with strong government contract deliveries, prompting an upward revision of full-year revenue guidance to as much as US$18.9 million.